Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' REILLY TM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 73 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Walton, HL; Corjay, MH; Mohamed, SN; Mousa, SA; Santomenna, LD; Reilly, TM
      Hypoxia induces differential expression of the integrin receptors alpha(v beta 3) and alpha(v beta 5) cultured human endothelial cells

      JOURNAL OF CELLULAR BIOCHEMISTRY
    2. Racanelli, AL; Gibbs, SK; Schlingmann, KL; Corjay, MH; Jadhav, PK; Reilly, TM
      Inhibition of neointima formation by a nonpeptide alpha(v)beta(3) integrinreceptor antagonist in a rabbit cuff model

      JOURNAL OF CELLULAR BIOCHEMISTRY
    3. Scholl, TO; Reilly, TM
      Trace element and mineral nutrition in human pregnancy

      CLINICAL NUTRITION OF THE ESSENTIAL TRACE ELEMENTS AND MINERALS
    4. Mousa, SA; Lorelli, W; Mohamed, S; Batt, DG; Jadhav, PK; Reilly, TM
      alpha(v)beta(3) integrin binding affinity and specificity of SM256 in various species

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    5. Barrett, JS; Yu, J; Kapil, R; Padovani, P; Brown, F; Ebling, WF; Corjay, MH; Reilly, TM; Bozarth, JM; Mousa, SA; Pieniaszek, HJ
      Disposition and exposure of the fibrinogen receptor antagonist XV459 on alpha(IIB)beta(3), binding sites in the guinea pig

      BIOPHARMACEUTICS & DRUG DISPOSITION
    6. Seiffert, D; Mitchell, TJ; Wang, ZY; Knabb, RM; Barbera, F; Reilly, TM; Thoolen, M
      Prothrombin activation in rabbits

      THROMBOSIS RESEARCH
    7. Olson, RE; Sielecki, TM; Wityak, J; Pinto, DJ; Batt, DG; Frietze, WE; Liu, J; Tobin, AE; Orwat, MJ; Di Meo, SV; Houghton, GC; Lalka, GK; Mousa, SA; Racanelli, AL; Hausner, EA; Kapil, RP; Rabel, HR; Thoolen, MJ; Reilly, TM; Anderson, PS; Wexler, RR
      Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of action

      JOURNAL OF MEDICINAL CHEMISTRY
    8. WACHTFOGEL YT; KETTNER C; HACK CE; NUIJENS JH; REILLY TM; KNABB RM; KUCICH U; NIEWIAROWSKI S; EDMUNDS LH; COLMAN RW
      THROMBIN AND HUMAN PLASMA KALLIKREIN INHIBITION DURING SIMULATED EXTRACORPOREAL-CIRCULATION BLOCK PLATELET AND NEUTROPHIL ACTIVATION

      Thrombosis and haemostasis
    9. MOUSA SA; OLSON RE; BOZARTH JM; LORELLI W; FORSYTHE MS; RACANELLI A; GIBBS S; SCHLINGMAN K; BOZARTH T; KAPIL R; WITYAK J; SIELECKI TM; WEXLER RR; THOOLEN MJ; SLEE A; REILLY TM; ANDERSON PS; FRIEDMAN PA
      ORAL ANTIPLATELET EFFICACY AND SPECIFICITY OF A NOVEL NONPEPTIDE PLATELET GPIIB IIIA RECEPTOR ANTAGONIST, DMP-802/

      Journal of cardiovascular pharmacology
    10. MOUSA SA; BOZARTH JM; LORELLI W; FORSYTHE MS; THOOLEN MJMC; SLEE AM; REILLY TM; FRIEDMAN PA
      ANTIPLATELET EFFICACY OF XV459, A NOVEL NONPEPTIDE PLATELET GPIIB IIAANTAGONIST - COMPARATIVE PLATELET BINDING PROFILES WITH C7E3/

      The Journal of pharmacology and experimental therapeutics
    11. REILLY TM; SELDES R; LUCHETTI W; BRIGHTON CT
      SIMILARITIES IN THE PHENOTYPIC-EXPRESSION OF PERICYTES AND BONE-CELLS

      Clinical orthopaedics and related research
    12. SRIVATSA SS; REILLY TM; HOLMES DR; SCHWARTZ RS; MOUSA SA
      COMBINED ALPHA-V-BETA-3 AND PLATELET IIB IIIA INTEGRIN BLOCKADE POTENTLY LIMITS NEOINTIMAL HYPERPLASIA AND LUMEN STENOSIS IN THE PORCINE CORONARY INJURY MODEL/

      Journal of the American College of Cardiology
    13. REILLY TM; RACANELLI AL; OLSON RE; WITYAK J; WEXLER RR; HAUSNER EA; THOOLEN MJ; MOUSA SA
      ANTIPLATELET EFFICACY OF ORALLY-ADMINISTERED DMP802, A GPIIB IIIA RECEPTOR ANTAGONIST, IN THE CONSCIOUS DOG/

      Journal of the American College of Cardiology
    14. MOUSA SA; MU DX; REILLY TM
      INTRAVENOUS AND ORAL ANTITHROMBOTIC EFFICACY OF A NOVEL NONPEPTIDE ANTIPLATELET GPIIB IIIA ANTAGONIST, DMP-754 AS COMPARED TO OTHER ANTIPLATELET AND ANTICOAGULANT STRATEGIES/

      Thrombosis and haemostasis
    15. XUE CB; WITYAK J; SIELECKI TM; PINTO DJ; BATT DG; CAIN GA; SWORIN M; ROCKWELL AL; RODERICK JJ; WANG SG; ORWAT MJ; FRIETZE WE; BOSTROM LL; LIU J; HIGLEY CA; RANKIN FW; TOBIN AE; EMMETT G; LALKA GK; SZE JY; DIMEO SV; MOUSA SA; THOOLEN MJ; RACANELLI AL; HAUSNER EA; REILLY TM; DEGRADO WF; WEXLER RR; OLSON RE
      DISCOVERY OF AN ORALLY-ACTIVE SERIES OF ISOXAZOLINE GLYCOPROTEIN IIB IIIA ANTAGONISTS/

      Journal of medicinal chemistry
    16. MOUSA SA; BOZARTH JM; FORSYTHE MS; THOOLEN M; REILLY TM; WITYAK J; OLSON RE; SIELECKI TM
      XV454, A NOVEL NONPEPTIDE ANTIPLATELET AGENT WITH COMPARABLE PLATELETALPHA-IIB-BETA-3 BINDING-KINETICS TO C7E3 AND LONG-LASTING ANTIPLATELET EFFICACY AFTER SINGLE INTRAVENOUS OR ORAL-ADMINISTRATION IN NONHUMAN-PRIMATES

      Circulation
    17. SEIFFERT DA; MITCHELL TJ; KNABB RM; BARBERA F; REILLY TM; THOOLEN M
      EVIDENCE THAT MEIZOTHROMBIN IS THE MAJOR PROTHROMBIN ACTIVATION PRODUCT GENERATED IN RABBITS

      Circulation
    18. RACANELLI AL; FLINT SK; SCHLINGMANN KL; CORJAY MH; STOLTENBORG JK; DIAMOND SM; SLEE AM; REILLY TM
      INHIBITION OF NEOINTIMAL FORMATION BY A NONPEPTIDE ALPHA-V-BETA-3 ANTAGONIST IN A RABBIT MODEL

      Circulation
    19. SRIVATSA SS; FITZPATRICK LA; TSAO PW; REILLY TM; HOLMES DR; SCHWARTZ RS; MOUSA SA
      SELECTIVE ALPHA-V-BETA-3 INTEGRIN BLOCKADE POTENTLY LIMITS NEOINTIMALHYPERPLASIA AND LUMEN STENOSIS FOLLOWING DEEP CORONARY ARTERIAL STENTINJURY - EVIDENCE FOR THE FUNCTIONAL IMPORTANCE OF INTEGRIN ALPHA-V-BETA-3 AND OSTEOPONTIN EXPRESSION DURING NEOINTIMA FORMATION

      Cardiovascular Research
    20. MOUSA SA; FORSYTHE M; LORELLI W; BOZARTH J; XUE CB; WITYAK J; SIELECKI TM; OLSON RE; DEGRADO W; KAPIL R; HUSSAIN M; WEXLER R; THOOLEN MJ; REILLY TM
      NOVEL NONPEPTIDE ANTIPLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST, DMP754 - RECEPTOR-BINDING AFFINITY AND SPECIFICITY/

      Coronary artery disease
    21. MOUSA SA; FORSYTHE M; REILLY TM
      PLATELET - ENDOTHELIAL-CELL INTERACTIONS IN MEDIATING THE RELEASE OF PLASMINOGEN-ACTIVATOR INHIBITOR-1

      Biochemical archives
    22. LUNA J; TOBE T; MOUSA SA; REILLY TM; CAMPOCHIARO PA
      ANTAGONISTS OF INTEGRIN ALPHA(V)BETA(3) INHIBIT RETINAL NEOVASCULARIZATION IN A MURINE MODEL

      Laboratory investigation
    23. SRIVATSA SS; REILLY TM; HOLMES DR; SCHWARTZ RS; MOUSA SA
      SELECTIVE ALPHA-V BETA-3 INTEGRIN BLOCKADE LIMITS NEOINTIMAL HYPERPLASIA AND LUMEN STENOSIS IN THE STENTED PORCINE CORONARY-ARTERY INJURY MODEL

      Circulation
    24. RACANELLI AL; KAPIL RP; MOUSA SA; REILLY TM; THOOLEN MJ
      ORAL ANTIPLATELET EFFECTS OF DMP-754 IN DOGS AND NONHUMAN-PRIMATES

      Circulation
    25. MOUSA SA; BOZARTH J; FORSYTHE M; WITYAK J; REILLY TM; MU DX
      INTRAVENOUS AND ORAL ANTIPLATELET ANTITHROMBOTIC EFFICACY AND SPECIFICITY OF XR300, A NOVEL NON PEPTIDE PLATELET GPIIB/IIIA ANTAGONIST/

      Circulation
    26. MOUSA SA; BOZARTH J; FORSYTHE M; XUE CB; WITYAK J; OLSON R; THOOLEN MJ; REILLY TM
      DISCOVERY OF A NOVEL NON PEPTIDE ANTIPLATELET GPIIB IIIA RECEPTOR ANTAGONIST, DMP-754 - RECEPTOR-BINDING AFFINITY AND SPECIFICITY/

      Circulation
    27. MOUSA SA; DEGRADO WF; MU DX; KAPIL RP; LUCCHESI BR; REILLY TM
      ORAL ANTIPLATELET, ANTITHROMBOTIC EFFICACY OF DMP-728, A NOVEL PLATELET GPIIB IIIA ANTAGONIST/

      Circulation
    28. REILLY TM; MOUSA SA; RACANELLI AL; THOOLEN MJ; FLINT SK; BOZARTH JM; MU DX; WALTON HL
      A MONOCLONAL-ANTIBODY THAT RECOGNIZES THE GPIIB IIIA ANTAGONIST DMP-728 - REVERSAL OF THE EFFECTS OF DMP-728 ON PLATELET-AGGREGATION AND BLEEDING-TIME IN THE DOG/

      Arteriosclerosis, thrombosis, and vascular biology
    29. MOUSA SA; BOZARTH JM; MU DX; LEAMY AW; ROTE WE; LUCCHESI BR; REILLY TM
      INTRAVENOUS AND ORAL ANTITHROMBOTIC EFFICACY OF THE PLATELET GPIIB IIIA ANTAGONIST, DMP728, IN DIFFERENT MODELS OF ARTERIAL THROMBOSIS/

      The FASEB journal
    30. REILLY TM; FORSYTHE MS; LUCCHESI BR; MOUSA SA
      THROMBOLYTIC AND ANTITHROMBOTIC EFFICACY OF THE PLATELET GPIIB IIIA ANTAGONIST DMP728/

      The FASEB journal
    31. WACHTFOGEL YT; HACK CE; NUIJENS JH; KETTNER C; REILLY TM; KNABB RM; BISCHOFF R; TSCHESCHE H; WENZEL H; KUCICH U; EDMUNDS LH; COLMAN RW
      SELECTIVE KALLIKREIN INHIBITORS ALTER HUMAN NEUTROPHIL ELASTASE RELEASE DURING EXTRACORPOREAL-CIRCULATION

      American journal of physiology. Heart and circulatory physiology
    32. MOUSA SA; MU DX; FORSYTHE M; LUCCHESI BR; REILLY TM
      ANTITHROMBOTIC AND THROMBOLYTIC EFFICACY OF THE PLATELET GPIIB IIIA ANTAGONIST DMP-728 IN ARTERIAL THROMBOSIS RETHROMBOSIS MODELS/

      Thrombosis and haemostasis
    33. MOUSA SA; MU DX; FALLON JT; REILLY TM
      ANIMAL-MODEL OF ARTERIAL AND VENOUS THROMBOSIS - ASSESSMENT OF THE EFFICACY OF VARIOUS ANTITHROMBOTIC STRATEGIES

      Thrombosis and haemostasis
    34. RACANELLI AL; FLINT SK; WALTON HL; MOUSA SA; REILLY TM
      REVERSAL OF GPIIB IIIA ANTAGONIST DMP-728-INDUCED BLEEDING IN THE DOG/

      Thrombosis and haemostasis
    35. MORIGUCHI A; TALLANT EA; MATSUMURA K; REILLY TM; WALTON H; GANTEN D; FERRARIO CM
      OPPOSING ACTIONS OF ANGIOTENSIN-(1-7) AND ANGIOTENSIN-II IN THE BRAINOF TRANSGENIC HYPERTENSIVE RATS

      Hypertension
    36. HUNG CT; POLLACK SR; REILLY TM; BRIGHTON CT
      REAL-TIME CALCIUM RESPONSE OF CULTURED BONE-CELLS TO FLUID-FLOW

      Clinical orthopaedics and related research
    37. MOUSA SA; DEGRADO WF; JACKSON S; FLINT SK; FORSYTHE MS; REILLY TM
      INTRAVENOUS AND ORAL ANTIPLATELET ANTITHROMBOTIC EFFICACY AND SPECIFICITY DMP757, A NOVEL PLATELET GPIIB IIIA ANTAGONIST/

      Circulation
    38. MITCHELL TJ; KNABB RM; CHRIST DD; FARMER AR; REILLY TM
      ANALYSIS OF THE THROMBIN INHIBITOR DUP-714 BY AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY

      Blood coagulation & fibrinolysis
    39. REILLY TM; MOUSA SA; SEETHARAM R; RACANELLI AL
      RECOMBINANT PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 - A REVIEW OF STRUCTURAL, FUNCTIONAL, AND BIOLOGICAL ASPECTS

      Blood coagulation & fibrinolysis
    40. MOUSA SA; FORSYTHE MS; DIEMER M; BOZARTH JM; REILLY TM
      THROMBOLYTIC AND ANTITHROMBOTIC EFFICACY OF THE PLATELET GPIIB-IIIA ANTAGONIST DMP728

      Coronary artery disease
    41. ROTE WF; DAVIS JH; MOUSA SA; REILLY TM; LUCCHESI BR
      ANTITHROMBOTIC EFFECTS OF DMP728, A FIBRINOGEN RECEPTOR (PLATELET GPIIB IIIA) ANTAGONIST/

      The FASEB journal
    42. HAIIALI AF; REILLY TM; WONG PC
      ROLE OF ANGIOTENSIN-II AND ALPHA-1-ADRENERGIC RECEPTORS IN THE RENAL VASOCONSTRICTOR ACTION OF N(G)-NITRO-L-ARGININE IN ANESTHETIZED RABBIT

      The FASEB journal
    43. MCCONNELL SJ; KENDALL ML; REILLY TM; HOESS RH
      CONSTRAINED PEPTIDE LIBRARIES AS A TOOL FOR FINDING MIMOTOPES

      Gene
    44. ROTE WE; DAVIS JH; MOUSA SA; REILLY TM; LUCCHESI BR
      ANTITHROMBOTIC EFFECTS OF DMP-728, A PLATELET GPIIB IIIA RECEPTOR ANTAGONIST, IN A CANINE MODEL OF ARTERIAL THROMBOSIS/

      Journal of cardiovascular pharmacology
    45. MOUSA SA; FLINT S; LORELLI W; HASSELL S; BOZARTH J; DEGRADO W; REILLY TM
      INTRAVENOUS ANTIPLATELET EFFICACY AND SAFETY OF THE PLATELET GPIIB IIIA ANTAGONIST, DMP-728 IN ANESTHETIZED DOGS/

      Thrombosis research
    46. MOUSA SA; BOZARTH J; FORSYTHE M; TSAO P; PEASE L; REILLY TM
      ROLE OF PLATELET GPIIB IIIA RECEPTORS IN THE MODULATION OF PLATELET PLASMINOGEN-ACTIVATOR INHIBITORS TYPE-1 (PAI-1) RELEASE/

      Life sciences
    47. HAJJALI AF; REILLY TM; WONG PC
      MODULATION OF RENAL VASOCONSTRICTOR EFFECT OF N-G-NITRO-L-ARGININE INRABBIT BY ANGIOTENSIN-II AND ALPHA-1-ADRENERGIC RECEPTOR BLOCKADE

      The Journal of pharmacology and experimental therapeutics
    48. HOESS RH; MACK AJ; WALTON H; REILLY TM
      IDENTIFICATION OF A STRUCTURAL EPITOPE BY USING A PEPTIDE LIBRARY DISPLAYED ON FILAMENTOUS BACTERIOPHAGE

      The Journal of immunology
    49. CHOMIAK PN; WALENGA JM; KOZA MJ; REILLY TM; TURLAPATHY P; PIFARRE R
      SYNTHETIC PEPTIDE THROMBIN INHIBITOR

      Circulation
    50. MOUSA SA; BOZARTH JM; FORSYTHE MS; JACKSON SM; LEAMY A; DIEMER MM; KAPIL RP; KNABB RM; MAYO MC; PIERCE SK; DEGRADO WF; THOOLEN MJ; REILLY TM
      ANTIPLATELET AND ANTITHROMBOTIC EFFICACY OF DMP-728, A NOVEL PLATELETGPIIB IIIA RECEPTOR ANTAGONIST/

      Circulation
    51. WACHTFOGEL YT; KETTNER C; HACK CE; NUIJENS JH; REILLY TM; KNABB RM; KUCICH U; NIEWIAROWSKI S; EDMUNDS LH; COLMAN RW
      THROMBIN INHIBITION DURING SIMULATED EXTRACORPOREAL-CIRCULATION BLOCKS PLATELET AND NEUTROPHIL ACTIVATION

      Blood
    52. MOUSA SA; DEGRADO WF; REILLY TM
      PLATELET-GPIIB IIIA ANTAGONISTS - HOW SAFE IS THIS ANTITHROMBOTIC APPROACH/

      The American journal of medicine
    53. PEASE LJ; ROBINSON CS; GILLIES PJ; BOZARTH JM; REILLY TM; MOUSA SA
      INCREASED PLATELET GPIIB IIIA RECEPTOR SENSITIVITY IN WATANABE HERITABLE HYPERLIPIDEMIC RABBITS/

      Biochemical archives
    54. MOUSA SA; FORSYTHE MS; DWIVEDI AM; REILLY TM
      PROTECTIVE EFFECT OF VITRONECTIN ON OXIDANT-INDUCED INACTIVATION OF RECOMBINANT PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (RPAI-1) - STRUCTURAL AND FUNCTIONAL-ANALYSIS

      Biochemical archives
    55. KRISHNAMURTI C; BOLAN CD; COLLETON CA; REILLY TM; ALVING BM
      COMPARISON OF THE THROMBOGENIC EFFECTS OF ANCROD AND THROMBIN ON RENAL FIBRIN DEPOSITION IN RABBITS WITH ELEVATED LEVELS OF PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1)

      Thrombosis and haemostasis
    56. MITCHELL TJ; KNABB RM; REILLY TM
      AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR QUANTITATION OF DUP 714, A SPECIFIC THROMBIN INHIBITOR

      Thrombosis and haemostasis
    57. CHOMIAK PN; WALENGA JM; KOZA MJ; REILLY TM; TURLAPATHY P; PIFARRE R
      A THROMBIN INHIBITOR PEPTIDE AS AN ALTERNATIVE TO HEPARIN IN CARDIOPULMONARY BYPASS-SURGERY

      Thrombosis and haemostasis
    58. MOUSA SA; FORSYTHE MS; BOZARTH JM; REILLY TM
      EFFECT OF SINGLE ORAL DOSE OF ASPIRIN ON HUMAN PLATELET FUNCTIONS ANDPLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1)

      Thrombosis and haemostasis
    59. MOUSA SA; BOZARTH JM; MAYO MC; FORSYTHE MS; REILLY TM
      COMPARATIVE ANTIPLATELET EFFECTS OF DIFFERENT THROMBIN INHIBITORS - KINETIC-ANALYSIS

      Thrombosis and haemostasis
    60. MOUSA SA; MAYO MC; BOZARTH JM; FORSYTHE MS; REILLY TM
      ANTIPLATELET EFFECTS OF THROMBIN INHIBITORS VERSUS GPIIB IIIA RECEPTOR ANTAGONISTS - COMPARATIVE KINETIC AND MECHANISTIC ANALYSIS/

      Thrombosis and haemostasis
    61. REILLY TM; SISK WP; DUKE JL; LORELLI WF; WALTON HL
      INTERACTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 REACTIVE CENTER VARIANTS WITH VITRONECTIN

      Thrombosis and haemostasis
    62. REILLY TM; LORELLI WF; PIERCE SK; SPITZ SM; WALTON HL
      MONOCLONAL-ANTIBODIES AGAINST A RECOMBINANT FORM OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 - EFFECTS ON TISSUE-PLASMINOGEN ACTIVATOR NEUTRALIZING AND VITRONECTIN BINDING-PROPERTIES

      Thrombosis and haemostasis
    63. SEETHARAM R; DWIVEDI AM; DUKE JL; HAYMAN AC; WALTON HL; HUCKINS NR; KAMERKAR SM; CORMAN JI; WOODESHICK RW; WILK RR; REILLY TM
      PURIFICATION AND CHARACTERIZATION OF ACTIVE AND LATENT FORMS OF RECOMBINANT PLASMINOGEN-ACTIVATOR INHIBITOR-1 PRODUCED IN ESCHERICHIA-COLI

      Thrombosis and haemostasis
    64. REILLY TM; LORELLI WF; PIERCE SK; SPITZ SM; WALTON HL
      MONOCLONAL-ANTIBODIES AGAINST A RECOMBINANT FORM OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 - EFFECTS ON TISSUE-PLASMINOGEN ACTIVATOR NEUTRALIZING AND VITRONECTIN BINDING-PROPERTIES

      Fibrinolysis
    65. REILLY TM; FORSYTHE MS; RACANELLI AL; SPITZ SM; WALTON HL; MOUSA SA
      RECOMBINANT PLASMINOGEN-ACTIVATOR INHIBITOR-1 PROTECTS PLATELETS AGAINST THE INHIBITORY EFFECTS OF PLASMIN

      Thrombosis research
    66. CHOMIAK PN; WALENGA JM; KOZA MJ; REILLY TM; TURLAPATHY P; PIFARRE R
      INVESTIGATION OF A THROMBIN INHIBITOR PEPTIDE AS AN ALTERNATIVE TO HEPARIN IN CARDIOPULMONARY BYPASS-SURGERY

      Circulation
    67. MOUSA SA; DEGRADO WF; JACKSON SA; THOOLEN MJ; PIERCE SK; BOZARTH JM; HASSELL SM; REILLY TM
      ANTIPLATELET EFFICACY AND SAFETY OF THE PLATELET GPIIB IIIA ANTAGONIST, DMP-728 IN ANESTHETIZED DOGS/

      Circulation
    68. ROTE WE; MU DX; MOUSA SA; REILLY TM; LUCCHESI BR
      DMP728, A GPIIB IIIA ANTAGONIST, ENHANCES RT-PA-INDUCED CORONARY THROMBOLYSIS AND PREVENTS RETHROMBOSIS IN A CHRONIC CANINE MODEL/

      Circulation
    69. MOUSA SA; FORSYTHE MS; BOZARTH JM; REILLY TM
      EFFECT OF SINGLE ORAL DOSE OF ASPIRIN ON HUMAN PLATELET FUNCTIONS ANDPLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1

      Cardiology
    70. MOUSA SA; BOZARTH JM; FORSYTHE MS; LORELLI W; THOOLEN MJ; RAMACHANDRAN N; JACKSON S; DEGRADO W; REILLY TM
      ANTIPLATELET EFFICACY AND SPECIFICITY OF DMP728, A NOVEL PLATELET GPIIB IIIA RECEPTOR ANTAGONIST/

      Cardiology
    71. MOUSA SA; REILLY TM
      PHARMACOLOGICAL BLOCKADE OF PLATELET GPIIB IIIA AND THE INHERITED DISORDERS OF THE PLATELET GPIIB/IIIA (GLANZMANN THROMBASTHENIA) - HOW SAFE IS THIS ANTITHROMBOTIC APPROACH FOR BOTH ACUTE AND CHRONIC TREATMENTOF THROMBOEMBOLIC DISORDERS - BRIEF COMMUNICATION/

      Cardiology
    72. KRISHNAMURTI C; BOLAN C; COLLETON CA; REILLY TM; ALVING BM
      ROLE OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN PROMOTING FIBRIN DEPOSITION IN RABBITS INFUSED WITH ANCROD OR THROMBIN

      Blood
    73. VAUGHAN DE; DECLERCK PJ; REILLY TM; PARK K; COLLEN D; FASMAN GD
      DYNAMIC STRUCTURAL AND FUNCTIONAL-RELATIONSHIPS IN RECOMBINANT PLASMINOGEN-ACTIVATOR INHIBITOR-1 (RPAI-1)

      Biochimica et biophysica acta


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/01/21 alle ore 05:35:42